before and after igf 1 lr3 Recombinant Human IGF-I/IGF-1 GMP Protein, CF (8335D-GMP) by R&D Systems, Part of Bio-Techne IGF-1 LR3 does not promote

5/5 mg vial + 2 mL BAC water: Concentration = 2,500 mcg BPC-157 + 2,500 mcg TB-500 per mL 250 mcg dose (of each) = 10 units (0.1 mL) on a 100-unit insulin syringe 500 mcg dose (of each) = 20 units (0.2 mL) on a 100-unit insulin syringe Doses per vial: 20 doses at 250 mcg each, or 10 doses at 500 mcg each Supplies Needed (4-Week Loading at 500 mcg/day) 3 vials BPC-157/TB-500 blend (5/5 mg each) provides 30 doses at 500 mcg, covers 28 days with margin 3 vials bacteriostatic water (30 mL each) 30 insulin syringes (2931 gauge, 100-unit) Alcohol prep pads Administration Injection Technique Standard subcutaneous injection

Certificate of Analysis Certificate of Analysis (COA) for this batch is available on request

Mahadevan U, Wolf DC, Dubinsky M, Cortot A, Lee SD, Siegel CA, et al

This is where most diabetics inject

While supplementation is generally considered safe, the lack of extensive clinical trials means you should always involve your healthcare provider in the decision